Lipid accumulation inhibits the reciprocal transcriptional activation between RelA and HNF1α, thereby impairing RelA signaling and further promoting the progression of MASLD. The gene discussed is HNF1A; the disease is metabolic dysfunction-associated steatotic liver disease.